Manufacturer record
Unimarck Healthcare Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
13 batches manufactured by Unimarck Healthcare Ltd (Uttarakhand) were declared Not of Standard Quality between January 2019 and April 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
13 records linked to Unimarck Healthcare Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Labetalol Hydrochloride Tablets IP 100 mg | UGT231341Mfg 2023-10 · Exp 2025-09 | Test For Assay(Content) of Labetalol HydrochlorideAssay | Government of NCT of DelhiState lab | Apr 2025 |
| Fexofenadine Hydrochloride Tablets I.P. 120 mg. | UGT231163Mfg 2023-08 · Exp 2025-07 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jan 2025 |
| Mesalazine Prolonged-release Tablets IP 1200 mg | UGT23128Mfg 2023-01 · Exp 2024-12 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2024 |
| Rosuvastatin, Aspirin and Clopidogrel Capsules | UGC22071Mfg 2022-03 · Exp 2024-02 | Description, Assay & Dissolution of RosuvastatinAssay | CDL KolkataCDSCO lab | Feb 2023 |
| B-complex capsules | UGC22020Mfg 2022-01 · Exp 2023-06 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| B-Complex Capsules | UGC22130Mfg 2022-06 · Exp 2023-11 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| B-Complex Capsules | UGC22131Mfg 2022-06 · Exp 2023-11 | DescriptionDescription | RDTL GuwahatiState lab | Jan 2023 |
| B - Complex Capsules | UGC22022Mfg 2022-01 · Exp 2023-06 | DescriptionDescription | RDTL GuwahatiState lab | Nov 2022 |
| B - Complex Capsules | UGC22048Mfg 2022-02 · Exp 2023-07 | DescriptionDescription | RDTL GuwahatiState lab | Nov 2022 |
| Misoprostol Tablets I.P. 200 mcg | UHT21422Mfg 2021-12 · Exp 2023-11 | AssayAssay | CDL KolkataCDSCO lab | Sep 2022 |
| Misoprostol Tablets IP 200mcg | UHT21298Mfg 2021-09 · Exp 2023-08 | AssayAssay | RDTL GuwahatiState lab | May 2022 |
| Clidinium Bromide, Chlordiazepoxide and Magnesium Hydroxide Tablets (Ulcon Tablets) | ULGT20031Mfg 2020-01 · Exp 2021-12 | Assay of Clidinium BromideAssay | RDTL ChandigarhCDSCO lab | Aug 2020 |
| Pantoprazole Sodium and Domperidone Tablets (PIZA-D TABLETS) | UGT17898Mfg 2017-12 · Exp 2019-11 | Assay of DomperidoneAssay | RDTL ChandigarhState lab | Jan 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.